You are here
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
SBC: SensoDX II, LLC Topic: A16AT008
The synthetic opioids fentanyl and carfentanil pose an imminent national security threat, given the ease with which they can be obtained, their low lethal doses, and their potential for weaponized use. The purpose of this agreement is to adapt SensoDx’s high-performance miniaturized diagnostics platform based on a programmable bio-nano-chip, with embedded artificial intelligence, to enable U.S. ...SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
SBC: BIOMACHINES, INC. Topic: CBD02101
In the wake of the September 11th attacks and subsequent Anthrax scares, researchers worldwide are working to expand our ability to rapidly assess what poses a terrorism threat to the public. The rapid detection of specific pathogens is required for biodSBIR Phase II 2004 Department of DefenseOffice for Chemical and Biological Defense